新型HLA-DPB1*1650:01 N基因被通过下一代测序识别
Min-Kyung So1, Seunghwan Kim1, Sori Lim2
1Department of Laboratory Medicine, Ewha Womans University College of Medicine, Seoul, Republic of Korea.
HLA
|August 27, 2025
概括
一个新的HLA-DPB1*1650:01:01:01等位基因因因单核酸变化而与HLA-DPB1*135:01:01:01不同,导致异位基因2的过早停止.
科学领域:
- 免疫遗传学
- 分子生物学
背景情况:
- 人类白细胞抗原 (HLA) 系统在免疫反应中起着至关重要的作用.
- HLA基因中的多态性,特别是HLA-DPB1,影响免疫系统功能和疾病易感性.
研究的目的:
- 为了描述新发现的HLA-DPB1等位基因,指定HLA-DPB1*1650:01:01.
- 确定这种新等位基因与已知等位基因区分的特定基因变异.
主要方法:
- 对HLA-DPB1基因进行序列分析.
- 新型基因序列与现有的HLA-DPB1参考序列的比较.
主要成果:
- 发现了新的HLA-DPB1*1650:01:01.
- 该等位基因与HLA-DPB1*135:01:01:01在第2个异位基因,第62个代号不同,具有CAG到TAG核酸替代.
- 这种替代导致过早停止子.
结论:
- 发现HLA-DPB1*1650:01:01扩大了已知的HLA-DPB1等位基因库.
- 过早停止的代码可能会影响HLA-DPB1蛋白的功能和表达.
相关概念视频
Next-generation Sequencing
87.9K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
87.9K
Single Nucleotide Polymorphisms-SNPs
14.6K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
14.6K
Genome-wide Association Studies-GWAS
12.6K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.6K


